Avanade RPA Partnerships in Healthcare Revenue Cycle

What Are Avanade's RPA Partnerships in Healthcare Revenue Cycle?

Avanade's RPA partnerships in healthcare revenue cycle operations pair Microsoft's Power Automate platform with Avanade's health system consulting practice, building bots that check claim status, verify eligibility, and route denials into existing workflows.

Avanade is now wholly owned by Accenture, which bought out Microsoft's stake in 2020, though the companies remain close technology partners on Power Automate and other Microsoft cloud tools.

That last part matters. Avanade rarely sells RPA as a standalone product. It shows up bundled with Dynamics 365, Azure data platforms, or a wider digital transformation program, which is why the price tag and timeline often run larger than the automation itself would justify. See Avanade's own healthcare page for how it positions the offering.

How Does Conduent's RPA Approach to Healthcare Revenue Cycle Differ?

Conduent RPA for healthcare revenue cycle work is typically sold as part of a full business process outsourcing contract, not a discrete automation project. Conduent's teams run the bots themselves as part of managed billing operations.

That's a meaningfully different model from Avanade's build-and-hand-off approach. A health system using Conduent is outsourcing the revenue cycle function; a health system using Avanade is buying automation tooling for a function it still runs in-house. Neither model is wrong, but conflating them during vendor selection leads to mismatched expectations about who owns exceptions when a bot fails.

Why Are Health Systems Turning to RPA for Revenue Cycle Management?

Revenue cycle teams run high volumes of repetitive, rules-based tasks across systems that rarely talk to each other natively. That combination, high volume plus poor system integration, is exactly what RPA is built for; Gartner defines RPA as software that mimics the actions of a human worker executing structured, rules-based digital tasks, which is precisely the profile of eligibility checks and claims polling.

Eligibility verification, claims status polling, and prior authorization checks all involve logging into a payer portal, reading a result, and keying it back into the EHR. A biller doing this manually all day is expensive and error-prone. A bot doing it correctly the first time, every time, changes the unit economics of the whole department.

Add up eligibility checks, claim status polls, and remittance postings across a single hospital system, and the volume alone justifies automation before considering the error rate manual entry introduces. Administrative complexity like this is a recurring theme in McKinsey's healthcare research, which repeatedly flags back-office process inefficiency as a larger cost driver than clinical care variation in many US health systems.

Where Does RPA Deliver the Clearest ROI?

RPA pays off fastest on high-volume, low-variance tasks: eligibility checks, claim status lookups, and posting electronic remittance advice. These follow the same steps every time regardless of patient or payer.

Denial routing is the second clearest win. Categorizing a denial by reason code and sending it to the right work queue is rules-based and repetitive, which is exactly the profile RPA handles well without needing judgment calls.

Where Does RPA Hit Its Limits?

RPA struggles wherever a task requires interpretation rather than rule-following. Appeals that need clinical documentation review, payer negotiations, or free-text denial reasons resist a scripted bot.

That's the limit worth naming before signing any RPA contract. Automation speeds up the workflow around a denial; it does not address the coding or documentation gap that caused the denial. Health systems that expect RPA to reduce their denial rate on its own are usually disappointed within two quarters.

Avanade vs Conduent vs a Specialist Partner: How Do They Compare?

The three models differ mainly in scope, ownership, and how fast a first automation goes live. Here's the practical comparison, broken down by what actually changes between them:

• Model. Avanade builds automation on Microsoft's stack, then hands it off. Conduent embeds RPA inside an outsourced operation. A specialist partner scopes and builds one automation only.
• Typical first pilot. Avanade: 2-4 months. Conduent: 3-6+ months, since you're transitioning an entire function. A specialist partner: 3-6 weeks for one workflow.
• Who runs the bots day to day. The health system, once Avanade hands off. Conduent itself, as part of its managed service. Either party, depending on what the contract specifies.
• Pricing model. Avanade charges a project fee plus Microsoft licensing. Conduent bundles cost into the BPO contract. A specialist partner prices a fixed scope per workflow.
• Best fit. Avanade suits a system already on Microsoft/Dynamics. Conduent suits one offloading billing entirely. A specialist partner suits one or two workflows that need speed.

Match the engagement model to what you actually need, not what a vendor's sales team defaults to.

What Does an Avanade RPA Partnership in Healthcare Revenue Cycle Cost?

An enterprise RPA engagement through a large systems integrator like Avanade typically starts in the low six figures for a pilot covering two or three workflows. That figure usually excludes ongoing Power Automate licensing and support retainers.

The cost isn't unreasonable for a health system already committed to the Microsoft ecosystem, since the automation work shares infrastructure with other projects. It's a poor fit for a system that only needs one workflow automated and doesn't want a multi-month discovery phase attached to it. Statista's RPA market data shows the software category has grown fastest among large enterprises for exactly this reason: the tooling and licensing costs amortize better across a bigger transformation program than a single narrow workflow.

When Does a Large Systems Integrator Make Sense?

A large SI partnership makes sense when RPA is one piece of a broader platform migration, not a standalone fix.

If you're already moving to Dynamics 365 or consolidating on Azure, bundling revenue cycle automation into that work avoids standing up a second vendor relationship just for RPA.

It also suits organizations with the internal governance to manage a multi-team, multi-quarter rollout, since that's the pace these engagements run at by design.

When Should You Consider a Specialist Partner Instead?

A specialist partner fits when the need is narrow: one denial category, one payer's claims format, one manual queue that's burning staff hours. Scoping stays tight and deployment measures in weeks, not quarters.

This is also the right call for health systems that want AI workflow automation paired with the RPA layer, since bots alone can't read unstructured denial letters or clinical notes the way a document-processing model can. A narrower partner can build that combination without the platform lock-in a large SI engagement carries.

How Does Viithiisys Approach Revenue Cycle Automation?

Viithiisys has delivered 212 projects since 2007 (per our case studies), engineering out of the Chandigarh tricity in India with a Canadian office in Markham, Ontario, for clients across six countries including Paytm, Snapdeal, IKEA, Nestle, Shiprocket, and Vikram Solar.

Full project detail sits in those case studies, a more verifiable way to evaluate a vendor than a capabilities deck.

The closest direct parallel to revenue cycle work in that portfolio is Fitelo, a health and wellness platform where Viithiisys built the voice-agent layer that answers routine dietary questions and routes harder cases to a human dietician.

It isn't clinical revenue cycle management, but the pattern matches what denial routing needs: automate the repetitive first pass, escalate anything that needs judgment, and measure how much of the queue never reaches a person.

For revenue cycle work specifically, that experience means pairing document AI for unstructured denial and EOB processing with targeted AI agent development for the decision logic RPA can't handle alone.

Health systems that want senior technical oversight without a full-time hire can also use fractional CTO engagements, priced from $100/hour as listed on that page, to validate the automation roadmap before committing budget.

What Should You Ask Before Signing an RPA Partnership?

Three questions cut through most vendor pitches. First: who owns the bot when a payer portal changes its layout and the automation breaks? Second: does pricing scale with transaction volume, or is it a flat annual fee regardless of usage?

Third, and most often skipped: what happens to the denial rate itself, not just the labor hours, six months in? A vendor that can't answer that with a number is selling activity, not outcomes.

What's the Practical First Step?

Before signing any RPA contract, map which revenue cycle tasks are actually rules-based versus which ones only look that way on a slide. That distinction determines whether you need a platform partnership or a scoped build.

A broken workflow assessment does exactly this: it identifies which of your revenue cycle bottlenecks are automatable today and which need a document or reasoning layer first. If you'd rather talk through your specific claims and denial volumes before scoping anything, get in touch.